AI assistant
Sending…
NEOGENOMICS INC — Director's Dealing 2016
Mar 14, 2016
32227_dirs_2016-03-14_e8cc655c-e4b6-466c-ab09-6bb0f3cc722f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2016-03-11
Reporting Person: CARDOZA GEORGE (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-03-11 | Common Stock | M | 100000 | $1.46 | Acquired | 221089 | Direct |
| 2016-03-11 | Common Stock | S | 32000 | $6.83 | Disposed | 189089 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-03-11 | Stock Option (Right to Buy) | $1.46 | X | 100000 | Disposed | 2016-04-13 | Common Stock (100000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 20000 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $3.45 | 2019-03-05 | Common Stock (30000) | 30000 | Direct |
| Stock Option (Right to Buy) | $4.78 | 2020-05-04 | Common Stock (200000) | 200000 | Direct |
Footnotes
F1: On April 14, 2011 Mr. Cardoza was granted an option to purchase 100,000 shares. These options vest ratably over the first four anniversary dates of the grant.
F2: On March 5, 2014 Mr. Cardoza was granted an option to purchase 30,000 shares. These options vest ratably over the first three anniversary dates of the grant.
F3: On May 4, 2015 Mr. Cardoza was granted an option to purchase 200,000 shares. These options vest ratably over the first three anniversary dates of the grant.
More from NEOGENOMICS INC
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24